Phillips AN - Search Results

1

Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales.

Witzel TC, Wright T, McCabe L, Gabriel MM, Wolton A, Gafos M, Ward D, Lampe FC, Phillips AN, Trevelion R, Collaco-Moraes Y, Harbottle J, Speakman A, Bonell C, Dunn DD, McCormack S, Burns FM, Weatherburn P, Rodger AJ. Witzel TC, et al. Among authors: phillips an. EClinicalMedicine. 2021 Feb 11;32:100700. doi: 10.1016/j.eclinm.2020.100700. eCollection 2021 Feb. EClinicalMedicine. 2021. PMID: 33681732 Free PMC article.

2

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.

Matthews GV, Sabin CA, Mandalia S, Lampe F, Phillips AN, Nelson MR, Bower M, Johnson MA, Gazzard BG. Matthews GV, et al. Among authors: phillips an. AIDS. 2002 Jan 4;16(1):53-61. doi: 10.1097/00002030-200201040-00008. AIDS. 2002. PMID: 11741163 Clinical Trial.

3

CD4 cell count changes in individuals with counts above 500 cells/mm and viral loads below 50 copies/ml on antiretroviral therapy.

Phillips AN, Youle M, Lampe F, Sabin CA, Hill A, Ransom D, Gumley H, Loveday C, Lipman M, Johnson M. Phillips AN, et al. AIDS. 2002 May 3;16(7):1073-5. doi: 10.1097/00002030-200205030-00016. AIDS. 2002. PMID: 11953476 No abstract available.

4

Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression.

Phillips AN, Staszewski S, Lampe F, Youle MS, Klauke S, Bickel M, Sabin CA, Doerr HW, Johnson MA, Loveday C, Miller V; Royal Free Centre for HIV Medicine; Goethe Universität Clinic Cohort. Phillips AN, et al. J Infect Dis. 2002 Oct 15;186(8):1086-91. doi: 10.1086/343801. Epub 2002 Sep 30. J Infect Dis. 2002. PMID: 12355358 Free article.

5

Viral breakthrough after suppression with highly active antiretroviral therapy: experience from 233 individuals with viral loads of less than 50 copies/ml followed for up to 4 years.

Lampe FC, Johnson MA, Lipman M, Loveday C, Youle M, Ransom D, Sabin CA, Tyrer M, Phillips AN. Lampe FC, et al. Among authors: phillips an. AIDS. 2003 Mar 28;17(5):768-70. doi: 10.1097/01.aids.0000050876.71999.11. AIDS. 2003. PMID: 12646806 No abstract available.

6

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy.

Smith CJ, Sabin CA, Lampe FC, Kinloch-de-Loes S, Gumley H, Carroll A, Prinz B, Youle M, Johnson MA, Phillips AN. Smith CJ, et al. Among authors: phillips an. AIDS. 2003 May 2;17(7):963-9. doi: 10.1097/00002030-200305020-00004. AIDS. 2003. PMID: 12700445

7

Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infection.

Phillips AN, Youle MS, Lampe F, Johnson M, Sabin CA, Lepri AC, Loveday C. Phillips AN, et al. AIDS. 2003 May 2;17(7):1009-16. doi: 10.1097/00002030-200305020-00009. AIDS. 2003. PMID: 12700450

8

Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.

Smith CJ, Sabin CA, Youle MS, Kinloch-de Loes S, Lampe FC, Madge S, Cropley I, Johnson MA, Phillips AN. Smith CJ, et al. Among authors: phillips an. J Infect Dis. 2004 Nov 15;190(10):1860-8. doi: 10.1086/425075. Epub 2004 Oct 8. J Infect Dis. 2004. PMID: 15499544

9

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy.

Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, Prinz B, Youle M, Johnson MA. Sabin CA, et al. Among authors: phillips an. AIDS. 2004 Nov 5;18(16):2145-51. doi: 10.1097/00002030-200411050-00006. AIDS. 2004. PMID: 15577647

10

The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimens.

Colette JS, Sabin CA, Lampe FC, Shah S, Tyrer M, Youle MS, Cropley I, Johnson MA, Phillips AN. Colette JS, et al. Among authors: phillips an. Antivir Ther. 2005;10(3):459-67. Antivir Ther. 2005. PMID: 15918337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page